Mitogenic activity on human arterial smooth muscle cells is increased in the plasma of patients undergoing hemodialysis with cuprophane membranes.
Résumé
During hemodialysis on cuprophane membranes, platelets are activated and release in plasma alpha-granule-specific substances such as PF4 or platelet-derived growth factor (PDGF). PDGF is the main source of mitogenic activity found in serum. In vitro, it induces the proliferation of smooth muscle cells (SMC) which is known to be involved in the development of atherosclerotic lesions. Atherosclerosis is one of the major complications of uremic patients undergoing chronic hemodialysis. To investigate whether this complication could be due to the dialysis itself, we measured the mitogenic activity in plasma of 10 patients undergoing hemodialysis on cuprophane membrane, using human arterial SMC in culture. Mitogenic activity in plasma increased about 3-fold during dialysis. These results may provide an argument in favor of a contribution of platelet activation and release of mitogenic activity to atherosclerosis in patients dialysed with cuprophane membranes.
Mots clés
Female
Humans
Male
Middle Aged
Muscle
Smooth
Vascular/*cytology/drug effects
Platelet Activating Factor/pharmacology
Platelet-Derived Growth Factor/pharmacology
Renal Dialysis/methods
Uremia/therapy
Adult
Aged
Arteries/*cytology/drug effects
Blood Cells/*cytology
Cell Division/drug effects
Cellulose